537-21781-52324
2 vaccinations
8 coded responses
18 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 041 / ME
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-06
Registered in v-safe
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-02-06
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-07
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Cough, Dyspnoea, Pre-existing disease, Wheezing — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Asthma flare started yesterday and persists. It isn't rieved w8th bronchodilator. Ex are moderate and include cough/wheeze/sobMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Pre-existing disease, Rhinitis — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: Asthma exacerbation and rhinnitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Cough, Dyspnoea, Pre-existing disease, Wheezing — Feeling: Good · Site: Pain · Abdominal pain, Rash, not including the immediate area around the injection siteFree text: Still having asthma exacerbation with dyspnea, wheezing and coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Dyspnoea, Pre-existing disease, Wheezing — Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Sob/wheeze/asthma exacerbation sx are improving but still obviousMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 1MedDRA: Asthma, Pre-existing disease — Feeling: Poor · Headache, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Asthma exacerbationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-12
Survey response — day 7, dose 1MedDRA: Asthma — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Asthma symptoms-milder todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-26
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-03-06
Health check-in — day 7, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, NauseaAdult check-in
- 2021-03-13
- 2021-03-20
- 2021-03-27
-
2021-04-03
Survey response — day 35, dose 2MedDRA: Headache — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Unilateral headache that I first experienced 24 hoirs after my 2nd dose has returned and is constant and has lasted > 1 week. · Healthcare visit (other): Eval for headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-10
- 2021-05-29
-
2021-06-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-15
Call successfulParticipant prefers to complete VAERS report online
- 2021-08-28
-
2022-02-27
Survey response — 12 months, dose 2MedDRA: Anxiety, Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased anxiety worsening anhedoniaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Asthma flare started yesterday and persists. It isn't rieved w8th bronchodilator. Ex are moderate and include cough/wheeze/sob
Systemic reaction (other): Asthma exacerbation and rhinnitis
Systemic reaction (other): Still having asthma exacerbation with dyspnea, wheezing and cough
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Sob/wheeze/asthma exacerbation sx are improving but still obvious
Systemic reaction (other): Asthma exacerbation
Release 4 — day 7, dose 1
Systemic reaction (other): Asthma symptoms-milder today
Release 6 — day 35, dose 2
Symptoms: Unilateral headache that I first experienced 24 hoirs after my 2nd dose has returned and is constant and has lasted > 1 week.
Healthcare visit (other): Eval for headache
Release 11 — 12 months, dose 2
Symptoms: Increased anxiety worsening anhedonia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Headache | ✓ | ✓ | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rhinitis | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release